PRJ1217 NHS Breast Screening Programme (London)

Complete

Buyers

Value

£163,870,741

Classifications

  • Health services

Tags

  • tender

Submission Deadline

9 months ago

Published

1 year ago

Description

NHS England (London), hereafter referred to as “the Authority”, is seeking to commission the NHS Breast Screening Programme London (“the Services”).<br/><br/>The contract term will be 5 years with the option to extend for a further 2 years at the sole discretion of the Authority.<br/><br/>The contract will start on 01/04/2026 and end 31/03/2031, if the optional extension is utilised the contract end date will be 31/03/33.<br/><br/>The procurement will be organised into six Lots. There will be five Clinical Service Lots and one Admin Hub Lot:<br/><br/>Lot 1 = North Central London (NLBSS & CELBSS)<br/>Lot 2 = North East London (ONEBSS)<br/>Lot 3 = North West London (WolBSS)<br/>Lot 4 = South East London (SELBSS)<br/>Lot 5 = South West London (SWLBSS)<br/>Lot 6 = London & West Herts Admin Hub<br/><br/>There will be a tariff model for the clinical services on a cost and volume basis. Payment to the Admin Hub Lot will be on a block basis. Please see the ITT documents on the portal for further information.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete